Chicago, IL – NXT Capital announced today that it closed a senior credit facility in support of WestView Capital Partners’ acquisition of PharmaLink.
NXT Capital acted as Sole Lead Arranger, Sole Bookrunner, and Administrative Agent on this transaction.
“We are excited to collaborate with NXT Capital on this transaction given their proven track record and our longstanding relationship,” said Jeffrey Clark, Principal, WestView Capital Partners. “We look forward to working with NXT to support PharmaLink’s continued growth and commitment to providing innovative pharmaceutical supply chain solutions.”
PharmaLink is a leading provider of pharmaceutical reverse distribution, product recall, and returns credit management services. Trusted by manufacturers, wholesale distributors, and major pharmacies in various classes of trade, PharmaLink combines deep regulatory expertise with innovative technology to maximize inventory performance, ensure compliance, and protect public health.
WestView Capital is a Boston-based private equity firm focused on growth-oriented companies. We currently manage $2.7 billion in capital and have a successful track record of partnering with exceptional entrepreneurs in minority and majority recapitalizations, growth capital and buyout transactions.
NXT Capital provides structured financing solutions through its Direct Lending group and targets U.S.-based borrowers with EBITDA between $5 million and $50 million. Since NXT Capital’s inception in 2010, their Direct Lending team has closed over $32 billion in loan commitments in more than 520 platform transactions. NXT Capital is based in Chicago with offices in Atlanta, Dallas, and New York and is the direct lending focused wholly-owned subsidiary of ORIX Corporation USA.